Belatacept (Nulojix)


Indications for Prior Authorization:

  • Kidney transplant

Patients must meet the following criteria for the indication(s) above::

  • To prevent organ rejection in an adult (>18 yrs.) patient

The following indications do not meet the criteria for use established by the Western Health Advantage Pharmacy and Therapeutics Committee:

  • Any other diagnosis not listed in the approved indications AND
  • Patient is EBV seropositive



  • The recommended dose is up to 10 mg/Kg IV for six doses maximum over the first 12 weeks


  • Up to 5 mg/Kg IV every four weeks


Up to one year


Last review date: July 20, 2016

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.